[A Case of Sigmoid Colon Cancer with Bladder Invasion Successfully Treated with Chemotherapy with mFOLFOX6+Cetuximab].

A 70' woman presented to our hospital complaining of a weight loss and loss of appetite. She was diagnosed with advanced sigmoid colon cancer by colonoscopy, and CT scan showed that the tumor had invaded the bladder and left ovary, and showed enlarged para-aortic lymph nodes. The tumor was large, and it was determined that a total cystectomy was necessary for radical resection, it was decided to perform pre-operative chemotherapy. Because RAS gene has no mutation, the regimen chose mFOLFOX6, in addition to cetuximab. Although Grade 3 neutropenia was observed, there was no appearance of adverse events that were intolerant, and 6 courses were performed. The treatment resulted in a marked reduction of the tumor. An open sigmoid colon resection with bladder wall and left ovarian cyst were performed. Even after the operation, the course was good, and it was discharged from the hospital lightly on the 10th day after the operation. The histopathological diagnosis was moderately differentiated adenocarcinoma, ypT4b(bladder left ovary), ypN0, M0, ypStage Ⅱc, all with negative surgical margins. She remained recurrence-free for 6 months of postoperative follow up. Cetuximab combination regimen was considered to be an effective option.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2024-12-01
Citations
1
Primary Topic
Colorectal Cancer Surgical Treatments
Type
article
Field-Weighted Citation Impact
0.28
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[A Case of Sigmoid Colon Cancer with Bladder Invasion Successfully Treated with Chemotherapy with mFOLFOX6+Cetuximab].

Hisanori Hatano, Ken Konishi, Yuko Fukumoto, Kazuyuki Matsushita et al.
1 citations
PubMed
Colorectal Cancer Surgical Treatments
0.28
article

[A Case of Sigmoid Colon Cancer with Bladder Invasion Successfully Treated with Chemotherapy with mFOLFOX6+Cetuximab].

Hisanori Hatano, Ken Konishi, Yuko Fukumoto, Kazuyuki Matsushita, Kentaro Muranishi, Takayuki Minoji, Kazunori Nakaguchi, Takahiko Nishigaki, Isao Arai, Noriyoshi Sawabata, Sadayuki Doi, Keishi Sugimoto
article en
1 citations

Abstract

A 70' woman presented to our hospital complaining of a weight loss and loss of appetite. She was diagnosed with advanced sigmoid colon cancer by colonoscopy, and CT scan showed that the tumor had invaded the bladder and left ovary, and showed enlarged para-aortic lymph nodes. The tumor was large, and it was determined that a total cystectomy was necessary for radical resection, it was decided to perform pre-operative chemotherapy. Because RAS gene has no mutation, the regimen chose mFOLFOX6, in addition to cetuximab. Although Grade 3 neutropenia was observed, there was no appearance of adverse events that were intolerant, and 6 courses were performed. The treatment resulted in a marked reduction of the tumor. An open sigmoid colon resection with bladder wall and left ovarian cyst were performed. Even after the operation, the course was good, and it was discharged from the hospital lightly on the 10th day after the operation. The histopathological diagnosis was moderately differentiated adenocarcinoma, ypT4b(bladder left ovary), ypN0, M0, ypStage Ⅱc, all with negative surgical margins. She remained recurrence-free for 6 months of postoperative follow up. Cetuximab combination regimen was considered to be an effective option.

PubMedVol. 51(13)
Toyo Institute of Food Technology (JP)
Openalex Percentile: Top 32%
Colorectal Cancer Surgical Treatments
0.28
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.